ExL Pharma Announces The 5th Clinical Data Disclosure Summit, The Premier Event On Clinical Trial Transparency - January 12-13, 2010 - Washington DC

Main Category: Conferences
Also Included In: Clinical Trials / Drug Trials
Article Date: 08 Jan 2010 - 3:00 PDT

email to a friend   printer friendly   opinions  

It is now ExL Pharma's 5th year of providing the industry with an interactive forum where professionals can evaluate the current issues and discuss best approaches for overcoming the challenges in clinical trial transparency.

At the 5th Clinical Data Disclosure Summit, professionals will be able to ascertain variances in regulatory guidances and provide best practices and expertise to successfully handle the evolution of clinical trial disclosure.

Key sessions include:

• Results Reporting Workshop led by ClinicalTrials.gov
  
  
• Discussions on FDAAA and How to Stay Current Despite the Changing Environment
  
  
• Information About the Features and Developments in EudraCT
  
  
• Best practices for using technology to improve facilitation for trial disclosure
  
  
• Novartis India to share best practices for compliant registration with India's Clinical Trials Registry
  
  
• Interactive discussions with the administrators from the Brazilian and Chinese Registries
  
  
• The Vice President of GSK to lead discussion with PhRMA, Pfizer and JNJ about the evolution of clinical trial transparency

CONFERENCE EXHIBITORS:

The event is sponsored by companies including IntraSphere Technologies, SEC Associates, Virtify and Sylogent, and supported by the Society for Clinical Data Management (SCDM).

INFORMATION IS ONLINE:

The 5th Clinical Data Disclosure complete program is available for review.

REGISTRATION INFORMATION:

This event is open for registration. For registration information, visit the conference website

ABOUT EXL PHARMA:

ExL Pharma is a leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind a diverse conference portfolio, an experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community. For further details please visit ExL Pharma.

FOR FURTHER INFORMATION, PLEASE CONTACT:

To obtain further event information please contact:

Jasmaine John
Marketing Director
ExL Pharma
555 8th Avenue, Suite.310
New York, NY 10018
Direct: 212.400.6235
Fax: 888.221.6750
jjohn@exlpharma.com

Source:
Erica Twomey
ExL Pharma

• Additional
• References
• Citations